Doxorubicin‐based maintenance chemotherapy vs observation
3‐year OS · patients with epithelial ovarian cancer
Doxorubicin‐based maintenance chemotherapy showed no clear difference in 3‐year OS compared with observation (moderate certainty).
1 finding from 1 review
- RR 1 [0.86, 1.15]2 studies · 204 participantsModerate